Drawing for SAIBA ANIMAL HEALTH

USPTO serial 79325521

SAIBA ANIMAL HEALTH

Reviewed by CopyMark Law Group

Reg. 6920293Status 700Registered
Filing date
Status date
Registration date
Dec 13, 2022
Examiner
FOSTER, ALEXANDRA M.
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SAIBA ANIMAL HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert S. Broder

Robert S. Broder Collard & Roe, P.C.1077 Northern Blvd.Roslyn, NY 11576UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Amino-acid preparations for veterinary use; biochemical preparations for medical and veterinary purposes for treating chronic inflammatory diseases, cancer and allergy in pets; biochemical preparations for medical or veterinary purposes for treating chronic inflammatory diseases, cancer and allergy in pets; biological preparations for veterinary use for treating chronic inflammatory diseases, cancer and allergy in pets; pharmaceutical, veterinary and sanitary preparations for the treatment of chronic inflammatory diseases, cancer and allergy in pets; pharmaceutical and veterinary preparations for the treatment of chronic inflammatory diseases, cancer and allergy in pets; dietary supplements for animals for veterinary use; veterinary vaccines; veterinary preparations and substances for the treatment of chronic inflammatory diseases, cancer and allergy in petsACTIVE—
042Scientific research; scientific research for medical purposes; scientific and technological research services in the field of vaccinology; preparing scientific surveys relating to scientific research; scientific and technological services and research and development services relating thereto; computer-aided scientific research; providing information and data relating to scientific and technological research and development; advice on scientific and industrial researchACTIVE—
044Medical, dental and veterinary analyses in connection with the treatment of individuals; veterinary medicine services and providing information relating thereto; veterinary medicine services; medical and veterinary information services via the Internet; veterinary information services via the Internet; providing information relating to veterinary medicine servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 24, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 1, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 31, 2023FIMPFINAL DISPOSITION PROCESSED—
Mar 13, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 13, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 13, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 22, 2022DOCKASSIGNED TO EXAMINER—
Sep 27, 2022GPNXNOTIFICATION PROCESSED BY IB—
Sep 27, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 27, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 26, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 26, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 7, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 7, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 7, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 19, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 26, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 26, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 26, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 11, 2022RFNTREFUSAL PROCESSED BY IB—
Mar 22, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 22, 2022RFRRREFUSAL PROCESSED BY MPU—
Feb 19, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 18, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2022DOCKASSIGNED TO EXAMINER—
Nov 19, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 15, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 11, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance